CRISPR Therapeutics to use MaxCytes technology in its search for cancer gene therapies

CRISPR Therapeutics to use MaxCyte’s technology in its search for cancer gene therapies

02:41 EST 9 Nov 2018 | Proactive Investors

CRISPR will use MaxCyte’s Flow Electroporation technology to deliver its components into T-cells, which are known to attack the body’s own cells that have been infected by viruses

More From BioPortfolio on "CRISPR Therapeutics to use MaxCyte’s technology in its search for cancer gene therapies"